-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.0047.65% Upside
Anavex Life Sciences Corp. Frequently Asked Questions
-
What analysts cover Anavex Life Sciences Corp.?
Anavex Life Sciences Corp. has been rated by research analysts at Cantor Fitzgerald in the past 90 days.